Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Cell Physiol ; 238(10): 2373-2389, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37610047

ABSTRACT

Mutations in the Prominin-1 (Prom1) gene disrupt photoreceptor disk morphogenesis, leading to macular dystrophies. We have shown that human retinal pigment epithelial (RPE) homeostasis is under the control of Prom1-dependent autophagy, demonstrating that Prom1 plays different roles in the photoreceptors and RPE. It is unclear if retinal and macular degeneration caused by the loss of Prom1 function is a cell-autonomous feature of the RPE or a generalized disease of photoreceptor degeneration. In this study, we investigated whether Prom1 is required for mouse RPE (mRPE) autophagy and phagocytosis, which are cellular processes essential for photoreceptor survival. We found that Prom1-KO decreases autophagy flux, activates mTORC1, and concomitantly decreases transcription factor EB (TFEB) and Cathepsin-D activities in mRPE cells. In addition, Prom1-KO reduces the clearance of bovine photoreceptor outer segments in mRPE cells due to increased mTORC1 and reduced TFEB activities. Dysfunction of Prom1-dependent autophagy correlates with both a decrease in ZO-1 and E-cadherin and a concomitant increase in Vimentin, SNAI1, and ZEB1 levels, consistent with induction of epithelial-mesenchymal transition (EMT) in Prom1-KO mRPE cells. Our results demonstrate that Prom1-mTORC1-TFEB signaling is a central driver of cell-autonomous mRPE homeostasis. We show that Prom1-KO in mRPE leads to RPE defects similar to that seen in atrophic age-related macular degeneration and opens new avenues of investigation targeting Prom1 in retinal degenerative diseases.

2.
J Cell Mol Med ; 26(14): 3873-3890, 2022 07.
Article in English | MEDLINE | ID: mdl-35670018

ABSTRACT

Despite advances in molecular characterization, glioblastoma (GBM) remains the most common and lethal brain tumour with high mortality rates in both paediatric and adult patients. The signal transducer and activator of transcription 3 (STAT3) is an important oncogenic driver of GBM. Although STAT3 reportedly plays a role in autophagy of some cells, its role in cancer cell autophagy remains unclear. In this study, we found Serine-727 and Tyrosine-705 phosphorylation of STAT3 was constitutive in GBM cell lines. Tyrosine phosphorylation of STAT3 in GBM cells suppresses autophagy, whereas knockout (KO) of STAT3 increases ULK1 gene expression, increases TSC2-AMPKα-ULK1 signalling, and increases lysosomal Cathepsin D processing, leading to the stimulation of autophagy. Rescue of STAT3-KO cells by the enforced expression of wild-type (WT) STAT3 reverses these pathways and inhibits autophagy. Conversely, expression of Y705F- and S727A-STAT3 phosphorylation deficient mutants in STAT3-KO cells did not suppress autophagy. Inhibition of ULK1 activity (by treatment with MRT68921) or its expression (by siRNA knockdown) in STAT3-KO cells inhibits autophagy and sensitizes cells to apoptosis. Taken together, our findings suggest that serine and tyrosine phosphorylation of STAT3 play critical roles in STAT3-dependent autophagy in GBM, and thus are potential targets to treat GBM.


Subject(s)
AMP-Activated Protein Kinases , Autophagy-Related Protein-1 Homolog , Glioblastoma , Intracellular Signaling Peptides and Proteins , STAT3 Transcription Factor , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , Autophagy/genetics , Autophagy-Related Protein-1 Homolog/genetics , Autophagy-Related Protein-1 Homolog/metabolism , Glioblastoma/pathology , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Phosphorylation , STAT3 Transcription Factor/metabolism , Serine/metabolism , Tyrosine/metabolism
3.
Telemed J E Health ; 27(3): 303-307, 2021 03.
Article in English | MEDLINE | ID: mdl-32543302

ABSTRACT

Background: Teleretinal imaging has been demonstrated to increase diabetic patient compliance with annual retinal examinations, but few studies have examined patient behavior after screening. Compliance with eye specialist follow-up is critical to ensure remote detection programs improve long-term vision outcomes for patients with diabetes. Introduction: The purpose of this study was to assess the rate of eye specialist follow-up compliance after referral for diabetic retinopathy (DR) from a teleretinal imaging program in a large primary care group practice. Materials and Methods: This is a retrospective chart review study of patients examined through a teleretinal imaging program between June 2015 and October 2017. Data from an electronic medical record were used to determine whether patients who were referred for management of DR requiring treatment attended follow-up eye care appointments. Reasons for nonattendance were also identified. Results: During the study time period, there were 110 patients referred for detected vision-threatening DR. Of those patients, 62 (56.3%) had an eye examination within 3 months, 83 (75.5%) had an examination within 1 year, and 92 (83.6%) had an examination within the 30-month study period. Of the patients who had follow-up eye examinations, 62.7% confirmed the diagnosis of vision-threatening DR and 89.2% had some level of DR. Discussion: Teleretinal imaging programs not only increase patient compliance with diabetic retinal examinations but can also generate accurate referrals and yield high rates of compliance with follow-up. Conclusions: These findings suggest that evaluating patients for DR in the primary care setting is an effective method of detecting vision-threatening retinopathy. However, assuring patient follow-up and treatment for vision-threatening DR detected in primary care telemedical networks remains a challenge.


Subject(s)
Diabetes Mellitus , Diabetic Retinopathy , Telemedicine , Diabetic Retinopathy/diagnostic imaging , Follow-Up Studies , Humans , Mass Screening , Patient Compliance , Primary Health Care , Retrospective Studies
4.
Biochem Biophys Res Commun ; 498(3): 573-578, 2018 04 06.
Article in English | MEDLINE | ID: mdl-29522718

ABSTRACT

Proliferative vitreoretinopathy (PVR) is a common complication of open globe injury and the most common cause of failed retinal detachment surgery. The response by retinal pigment epithelial (RPE) cells liberated into the vitreous includes proliferation and migration; most importantly, epithelial to mesenchymal transition (EMT) of RPE plays a central role in the development and progress of PVR. For the first time, we show that knockdown of BIRC5, a member of the inhibitor of apoptosis protein family, using either lentiviral vector based CRISPR/Cas9 nickase gene editing or inhibition of survivin using the small-molecule inhibitor YM155, results in the suppression of EMT in RPE cells. Knockdown of survivin or inhibition of survivin significantly reduced TGFß-induced cell proliferation and migration. We further demonstrated that knockdown or inhibition of survivin attenuated the TGFß signaling by showing reduced phospho-SMAD2 in BIRC5 knockdown or YM155-treated cells compared to controls. Inhibition of the TGFß pathway using TGFß receptor inhibitor also suppressed survivin expression in RPE cells. Our studies demonstrate that survivin contributes to EMT by cross-talking with the TGFß pathway in RPE cells. Targeting survivin using small-molecule inhibitors may provide a novel approach to treat PVR disease.


Subject(s)
Epithelial-Mesenchymal Transition , Inhibitor of Apoptosis Proteins/genetics , Retinal Pigment Epithelium/cytology , Signal Transduction , Transforming Growth Factor beta/metabolism , CRISPR-Cas Systems , Cell Line , Cell Proliferation , Humans , Inhibitor of Apoptosis Proteins/antagonists & inhibitors , Inhibitor of Apoptosis Proteins/metabolism , Retinal Pigment Epithelium/metabolism , Survivin , Vitreoretinopathy, Proliferative/genetics , Vitreoretinopathy, Proliferative/metabolism
5.
Mol Pharmacol ; 91(1): 1-13, 2017 01.
Article in English | MEDLINE | ID: mdl-27913654

ABSTRACT

Targeting vascular endothelial growth factor (VEGF) is a common treatment strategy for neovascular eye disease, a major cause of vision loss in diabetic retinopathy and age-related macular degeneration. However, the decline in clinical efficacy over time in many patients suggests that monotherapy of anti-VEGF protein therapeutics may benefit from adjunctive treatments. Our previous work has shown that through decreased activation of the cytoskeletal protein paxillin, growth factor-induced ischemic retinopathy in the murine oxygen-induced retinopathy model could be inhibited. In this study, we demonstrated that VEGF-dependent activation of the Src/FAK/paxillin signalsome is required for human retinal endothelial cell migration and proliferation. Specifically, the disruption of focal adhesion kinase (FAK) and paxillin interactions using the small molecule JP-153 inhibited Src-dependent phosphorylation of paxillin (Y118) and downstream activation of Akt (S473), resulting in reduced migration and proliferation of retinal endothelial cells stimulated with VEGF. However, this effect did not prevent the initial activation of either Src or FAK. Furthermore, topical application of a JP-153-loaded microemulsion affected the hallmark features of pathologic retinal angiogenesis, reducing neovascular tuft formation and increased avascular area, in a dose-dependent manner. In conclusion, our results suggest that using small molecules to modulate the focal adhesion protein paxillin is an effective strategy for treating pathologic retinal neovascularization. To our knowledge, this is the first paradigm validating modulation of paxillin to inhibit angiogenesis. As such, we have identified and developed a novel class of small molecules aimed at targeting focal adhesion protein interactions that are essential for pathologic neovascularization in the eye.


Subject(s)
Benzoxazines/pharmacology , Focal Adhesion Protein-Tyrosine Kinases/metabolism , Paxillin/metabolism , Retinal Neovascularization/metabolism , Signal Transduction/drug effects , Small Molecule Libraries/pharmacology , Vascular Endothelial Growth Factor A/pharmacology , src-Family Kinases/metabolism , Animals , Cell Movement/drug effects , Cell Proliferation/drug effects , Disease Models, Animal , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Humans , Mice, Inbred C57BL , Models, Biological , Oxygen , Retinal Neovascularization/pathology
6.
Mamm Genome ; 26(5-6): 210-21, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25963977

ABSTRACT

The tumor suppressor p53 is a major regulator of genes important for cell cycle arrest, senescence, apoptosis, and innate immunity, and has recently been implicated in retinal aging. In this study we sought to identify the genetic networks that regulate p53 function in the retina using quantitative trait locus (QTL) analysis. First we examined age-associated changes in the activation and expression levels of p53; known p53 target proteins and markers of innate immune system activation in primary retinal pigment epithelial (RPE) cells that were harvested from young and aged human donors. We observed increased expression of p53, activated caspase-1, CDKN1A, CDKN2A (p16INK4a), TLR4, and IFNα in aged primary RPE cell lines. We used the Hamilton Eye Institute (HEI) retinal dataset ( www.genenetwork.org ) to identify genomic loci that modulate expression of genes in the p53 pathway in recombinant inbred BXD mouse strains using a QTL systems biology-based approach. We identified a significant trans-QTL on chromosome 1 (region 172-177 Mb) that regulates the expression of Cdkn1a. Many of the genes in this QTL locus are involved in innate immune responses, including Fc receptors, interferon-inducible family genes, and formin 2. Importantly, we found an age-related increase in FCGR3A and FMN2 and a decrease in IFI16 levels in RPE cultures. There is a complex multigenic innate immunity locus that controls expression of genes in the p53 pathway in the RPE, which may play an important role in modulating age-related changes in the retina.


Subject(s)
Aging , Immunity, Innate/genetics , Retinal Pigment Epithelium/metabolism , Tumor Suppressor Protein p53/metabolism , Adult , Aged, 80 and over , Animals , Apoptosis , Caspases/genetics , Caspases/metabolism , Caspases, Initiator , Cell Line , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Gene Expression Regulation , Humans , Interferon-alpha/genetics , Interferon-alpha/metabolism , Interferon-gamma/genetics , Interferon-gamma/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred DBA , Primary Cell Culture , Quantitative Trait Loci , Retinal Pigment Epithelium/cytology , Signal Transduction , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism , Tumor Suppressor Protein p53/genetics
9.
Analyst ; 140(1): 98-106, 2015 Jan 07.
Article in English | MEDLINE | ID: mdl-25327876

ABSTRACT

The performance of a membrane-coated voltammetric sensor for propofol (2,6-diisopropylphenol) has been characterized in long term monitoring experiments using an automated flow analytical system (AFAS) and by analyzing human serum and whole blood samples by standard addition. It is shown that the signal of the membrane-coated electrochemical sensor for propofol is not influenced by the components of the pharmaceutical formulation of propofol (propofol injectable emulsion). The current values recorded with the electrochemical propofol sensor in buffer solutions and human serum samples spiked with propofol injectable emulsion showed excellent correlation with the peak heights recorded with an UV-Vis detector during the HPLC analysis of these samples (R(2) = 0.997 in PBS and R(2) = 0.975 in human serum). However, the determination of propofol using the electrochemical method is simpler, faster and has a better detection limit (0.08 ± 0.05 µM) than the HPLC method (0.4 ± 0.2 µM). As a first step towards feedback controlled closed-loop anesthesia, the membrane-coated electrochemical sensor has been implemented onto surface of an intravenous catheter. The response characteristics of the membrane-coated carbon fiber electrode on the catheter surface were very similar to those seen using a macroelectrode.


Subject(s)
Anesthesia , Propofol/blood , Chromatography, High Pressure Liquid , Electrochemical Techniques , Humans
10.
Cornea ; 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39085991

ABSTRACT

PURPOSE: Anterior stromal puncture is an inexpensive and widely used technique at the slit lamp to treat recurrent corneal erosions (RCE), common sequelae of corneal abrasions, trauma, and epithelial basement membrane dystrophies (EBMDs). The purpose of this study was to determine safety of a novel anterior stromal micropuncture device (termed a "plexitome") for use in the optical axis of the cornea. METHODS: We performed an IRB-approved clinical pilot study on 45 patients with diverse corneal pathologies to determine the safety of the plexitome device and examined corneal healing responses clinically for a minimum of 30 days after treatment. Follow on efficacy data was collected for treated patients with RCE. Micropuncture treatment was performed either through loose epithelial tissue or after debridement using a cotton tip at the slit lamp. After "imprinting," patients were treated with topical medications including antibiotics, hypertonic saline/ointment, bandage contact lenses, and/or patching according to the treating physician's routine care for the condition. RESULTS: Micropuncture using the "plexitome" device did not create visible scars in the corneal stroma of the 45 patients treated and followed for at least 30 days. Photographic evidence of imprinting was seen at in 1 patient at 30 days. There were no significant adverse events associated with treatment. CONCLUSIONS: Micropuncture of the cornea using the "plexitome" device does not create optically evident anterior stromal scarring after treatment. Micropuncture using the device may be an effective way of treating RCE and other corneal manifestations of EBMD in the optical axis, which is not currently possible using standard anterior stromal puncture methods.

11.
Transl Vis Sci Technol ; 12(11): 28, 2023 11 01.
Article in English | MEDLINE | ID: mdl-38010283

ABSTRACT

Purpose: Cells grown in milliliter volume devices have difficulty measuring low-abundance secreted factors due to low resulting concentrations. Using microfluidic devices increases concentration; however, the constrained geometry makes phenotypic characterization with transepithelial electrical resistance more difficult and less reliable. Our device resolves this problem. Methods: We designed and built a novel microfluidic "Puck" assembly using laser-cut pieces from preformed sheets of silicone and commercial off-the-shelf parts. Transwell membranes containing polarized retinal pigment epithelial (RPE) cells were reversibly sealed within the Puck and used to study polarized protein secretion. Protein secretion from the apical and basal surfaces in response to hypoxic conditions was quantified using an immunoassay method. Computational fluid modeling was performed on the chamber design. Results: Under hypoxic culture conditions (7% O2), basal vascular endothelial growth factor (VEGF) secretion by polarized RPE cells increased significantly from 1.40 to 1.68 ng/mL over the first 2 hours (P < 0.0013) and remained stably elevated through 4 hours. Conversely, VEGF secretion from the apical side remained constant under the same hypoxic conditions. Conclusions: The Puck can be used to measure spatiotemporal protein secretion by polarized cells into apical and basal microniches in response to environmental conditions. Computational model results support the absence of biologically significant shear stress to the cells caused by the device. Translational Relevance: The Puck can be used validate the mature phenotypic health of autologous induced pluripotent stem cells (iPSC)-derived RPE cells prior to transplantation.


Subject(s)
Microfluidics , Vascular Endothelial Growth Factor A , Epithelial Cells/metabolism , Retinal Pigments
12.
Anal Chem ; 84(18): 7670-6, 2012 Sep 18.
Article in English | MEDLINE | ID: mdl-22900668

ABSTRACT

Propofol is a widely used, potent intravenous anesthetic for ambulatory anesthesia and long-term sedation. The target steady state concentration of propofol in blood is 0.25-10 µg/mL (1-60 µM). Although propofol can be oxidized electrochemically, monitoring its concentration in biological matrixes is very challenging due to (i) low therapeutic concentration, (ii) high concentrations of easily oxidizable interfering compounds in the sample, and (iii) fouling of the working electrode. In this work we report the performance characteristics of an organic film coated glassy carbon (GC) electrode for continuous monitoring of propofol. The organic film (a plasticized PVC membrane) improved the detection limit and the selectivity of the voltammetric sensor due to the large difference in hydrophobicity between the analyte (propofol) and interfering compounds of the sample, e.g., ascorbic acid (AA) or p-acetamidophenol (APAP). Furthermore, the membrane coating prevented electrode fouling and served as a protective barrier against electrode passivation by proteins. Studies revealed that sensitivity and selectivity of the voltammetric method is greatly influenced by the composition of the PVC membrane. The detection limit of the membrane-coated sensor for propofol in PBS is reported as 0.03 ± 0.01 µM. In serum-like electrolyte solutions containing physiologically relevant levels of albumin (5%) and 3 mM AA and 1 mM APAP as interfering agents, the detection limit was 0.5 ± 0.4 µM. Both values are below the target concentrations used clinically during anesthesia or sedation.


Subject(s)
Anesthetics, Intravenous/analysis , Electrochemical Techniques , Electrolytes/chemistry , Propofol/analysis , Acetaminophen/chemistry , Ascorbic Acid/chemistry , Electrodes , Membranes, Artificial , Oxidation-Reduction , Propofol/blood
13.
Exp Eye Res ; 99: 63-70, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22504073

ABSTRACT

We developed and characterized a mouse model of primary ocular blast injury. The device consists of: a pressurized air tank attached to a regulated paintball gun with a machined barrel; a chamber that protects the mouse from direct injury and recoil, while exposing the eye; and a secure platform that enables fine, controlled movement of the chamber in relation to the barrel. Expected pressures were calculated and the optimal pressure transducer, based on the predicted pressures, was positioned to measure output pressures at the location where the mouse eye would be placed. Mice were exposed to one of three blast pressures (23.6, 26.4, or 30.4 psi). Gross pathology, intraocular pressure, optical coherence tomography, and visual acuity were assessed 0, 3, 7, 14, and 28 days after exposure. Contralateral eyes and non-blast exposed mice were used as controls. We detected increased damage with increased pressures and a shift in the damage profile over time. Gross pathology included corneal edema, corneal abrasions, and optic nerve avulsion. Retinal damage was detected by optical coherence tomography and a deficit in visual acuity was detected by optokinetics. Our findings are comparable to those identified in Veterans of the recent wars with closed eye injuries as a result of blast exposure. In summary, this is a relatively simple system that creates injuries with features similar to those seen in patients with ocular blast trauma. This is an important new model for testing the short-term and long-term spectrum of closed globe blast injuries and potential therapeutic interventions.


Subject(s)
Anterior Eye Segment/injuries , Blast Injuries/etiology , Disease Models, Animal , Eye Injuries/etiology , Posterior Eye Segment/injuries , Wounds, Nonpenetrating/etiology , Animals , Blast Injuries/pathology , Body Weight , Cataract/etiology , Corneal Diseases/etiology , Eye Injuries/pathology , Female , Intraocular Pressure/physiology , Mice , Mice, Inbred BALB C , Tomography, Optical Coherence , Visual Acuity/physiology , Wounds, Nonpenetrating/pathology
14.
Talanta ; 239: 123072, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-34864535

ABSTRACT

Amitriptyline and its metabolite, Nortriptyline are commonly used tricyclic antidepressant (TCA) drugs that are electrochemically active. In this work, the performance characteristics of a plasticized PVC membrane-coated glassy carbon (GC) electrode are described for the voltammetric quantification of Amitriptyline and Nortriptyline in whole blood. The highly lipophilic Amitriptyline and Nortriptyline preferentially partition into the plasticized PVC membrane where the free drug is oxidized on the GC electrode. The concentrations of the drugs in the membrane are orders of magnitude larger than in the sample solution, resulting in superb limit of detection (LOD) of the membrane-coated voltammetric sensor: 3 nmol/L for Amitriptyline and 20 nmol/L for Nortriptyline. Conversely, hydrophilic components of the sample solution, e.g., proteins, the protein-bound fraction of the drugs, and electrochemically active small molecules are blocked from entering the membrane, which provides exceptional selectivity for the membrane-coated sensor and feasibility for the measurements of Amitriptyline in whole blood. In this work, the concentrations of Amitriptyline and Nortriptyline were determined in whole blood using the sensor and the results of our analysis were compared to the results of the standard HPLC-MS method. Based on our experience, the one-step voltammetric methods with the membrane-coated sensor may become a real alternative to the significantly more complex HPLC-MS analysis.


Subject(s)
Amitriptyline , Nortriptyline , Antidepressive Agents, Tricyclic , Chromatography, High Pressure Liquid , Limit of Detection
15.
Stem Cell Res Ther ; 13(1): 260, 2022 06 17.
Article in English | MEDLINE | ID: mdl-35715869

ABSTRACT

BACKGROUND: Mitochondrial dysfunction and mitochondrial DNA (mtDNA) damage in the retinal pigment epithelium (RPE) have been implicated in the pathogenesis of age-related macular degeneration (AMD). However, a deeper understanding is required to determine the contribution of mitochondrial dysfunction and impaired mitochondrial autophagy (mitophagy) to RPE damage and AMD pathobiology. In this study, we model the impact of a prototypical systemic mitochondrial defect, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), in RPE health and homeostasis as an in vitro model for impaired mitochondrial bioenergetics. METHODS: We used induced pluripotent stem cells (iPSCs) derived from skin biopsies of MELAS patients (m.3243A > G tRNA leu mutation) with different levels of mtDNA heteroplasmy and differentiated them into RPE cells. Mitochondrial depletion of ARPE-19 cells (p0 cells) was also performed using 50 ng/mL ethidium bromide (EtBr) and 50 mg/ml uridine. Cell fusion of the human platelets with the p0 cells performed using polyethylene glycol (PEG)/suspension essential medium (SMEM) mixture to generate platelet/RPE "cybrids." Confocal microscopy, FLowSight Imaging cytometry, and Seahorse XF Mito Stress test were used to analyze mitochondrial function. Western Blotting was used to analyze expression of autophagy and mitophagy proteins. RESULTS: We found that MELAS iPSC-derived RPE cells exhibited key characteristics of native RPE. We observed heteroplasmy-dependent impairment of mitochondrial bioenergetics and reliance on glycolysis for generating energy in the MELAS iPSC-derived RPE. The degree of heteroplasmy was directly associated with increased activation of signal transducer and activator of transcription 3 (STAT3), reduced adenosine monophosphate-activated protein kinase α (AMPKα) activation, and decreased autophagic activity. In addition, impaired autophagy was associated with aberrant lysosomal function, and failure of mitochondrial recycling. The mitochondria-depleted p0 cells replicated the effects on autophagy impairment and aberrant STAT3/AMPKα signaling and showed reduced mitochondrial respiration, demonstrating phenotypic similarities between p0 and MELAS iPSC-derived RPE cells. CONCLUSIONS: Our studies demonstrate that the MELAS iPSC-derived disease models are powerful tools for dissecting the molecular mechanisms by which mitochondrial DNA alterations influence RPE function in aging and macular degeneration, and for testing novel therapeutics in patients harboring the MELAS genotype.


Subject(s)
Induced Pluripotent Stem Cells , MELAS Syndrome , Macular Degeneration , Autophagy/genetics , DNA, Mitochondrial/genetics , Energy Metabolism/genetics , Epithelial Cells/metabolism , Humans , Induced Pluripotent Stem Cells/metabolism , MELAS Syndrome/genetics , MELAS Syndrome/metabolism , MELAS Syndrome/pathology , Macular Degeneration/metabolism , Mitochondria/genetics , Mitochondria/metabolism , Retinal Pigment Epithelium/metabolism , Retinal Pigments/metabolism
16.
J Cell Physiol ; 226(8): 2025-32, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21520054

ABSTRACT

Oxidative stress (OS) in the retina plays an important role in the development and progression of age-related macular degeneration (AMD). Our previous work has shown that OS can quantitatively regulate the expression of AP-1 family genes in the retinal pigment epithelium (RPE). In this study, we sought to determine whether AP-1 genes can be used as cellular biomarkers of OS to evaluate the efficacy of ascorbate, the major aqueous-phase antioxidant in the blood, in reducing OS in RPE cells in vitro. Human ARPE19 cells were pretreated with increasing levels of ascorbate (0-500 µM) for 3 days which was then removed from the medium. OS was induced 24 h later by the addition of hydrogen peroxide for 1-4 h, to bring the final media concentration of H(2)O(2) to 500 µM. FosB, c-Fos, and ATF3 gene expression was examined from 0 to 24 h after OS. Pretreatment with 200 µM ascorbate maximally reduced the transcriptional OS response of AP-1 genes by up to 87% after 1 and 4 h, compared to controls. One hundred micromolar of ascorbate provided a statistically significant, but far more modest effect. Ascorbate supplementation of 100-200 µM appears to strongly inhibit OS-induced activation of AP-1 in vitro, but pretreatment with higher levels of ascorbate conferred no additional advantage. These studies suggest that there are optimal levels of antioxidant supplementation to the RPE in vitro. Laboratory assays based upon transcription factor biomarkers may be useful to define beneficial molecular responses to new antioxidants, alternative dosing regimens, and to explore therapeutic efficacy in OS models in vitro.


Subject(s)
Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Oxidative Stress/drug effects , Retinal Pigment Epithelium/drug effects , Activating Transcription Factor 3/genetics , Activating Transcription Factor 3/metabolism , Biomarkers/metabolism , Cell Line , Gene Expression Regulation/drug effects , Humans , Hydrogen Peroxide/adverse effects , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , Retinal Pigment Epithelium/metabolism , Transcription Factor AP-1/genetics , Transcription Factor AP-1/metabolism
18.
Neurochem Res ; 36(4): 574-82, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21181264

ABSTRACT

The purpose of this study was to characterize the early molecular responses to quantified levels of serial oxidative stress (OS) in the human retinal pigment epithelium (RPE). Confluent ARPE-19 cells were cultured for 3 days in defined medium to stabilize gene expression. The cells were serially exposed to high levels of OS (500 µM H(2)O(2)) with up to 3 distinct stimuli presented 4 h apart. Gene expression was followed for at least 8 h following initiation of each OS. Using real time qPCR, we quantified the expression of immediate early genes from the AP-1 and EGR transcription factor families and other genes involved in regulating the redox status of the cells. Significant and quantitative changes were seen in the expression of five AP-1 transcription factor genes. The peak level of induced transcription from OS varied from two-fold to >64-fold over the first 4 h, depending on the gene and magnitude of OS. Serial responses were characterized and distinct types of quantifiable OS-specific responses were observed. The responses manifested controlled serial increases in expression of these genes in a manner dependent upon the rate of increase in transcription, the relative duration of the transcriptional stimulus, and the characteristic relaxation to the initial steady state. This complexity suggests a mechanism whereby the rate of increase in transcription directs alternative paths to effect downstream gene-specific responses to OS. The molecular mechanisms by which these signals are transduced and controlled in the RPE are speculative. However, the rapidity of the TF response, and the known autoregulation of TF promoters by their gene products suggests that the early control is likely mediated by phosphorylation and activation of existing AP-1 and EGR protein pools within the cell, modulated by the opposing activity of kinase and phosphatase enzymes. Because of the differences in both initial and serial responses to the input stresses, it appears that control theory may provide a useful characterization of the distinctions.


Subject(s)
Feedback , Gene Expression Regulation , Oxidative Stress , Retinal Pigment Epithelium/metabolism , Base Sequence , DNA Primers , Early Growth Response Protein 1/genetics , Humans , Polymerase Chain Reaction , Transcription Factor AP-1/genetics
19.
Telemed J E Health ; 17(8): 627-34, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21819244

ABSTRACT

In this article, we present the design and implementation of a regional ocular telehealth network for remote assessment and management of diabetic retinopathy (DR), including the design requirements, network topology, protocol design, system work flow, graphics user interfaces, and performance evaluation. The Telemedical Retinal Image Analysis and Diagnosis Network is a computer-aided, image analysis telehealth paradigm for the diagnosis of DR and other retinal diseases using fundus images acquired from primary care end users delivering care to underserved patient populations in the mid-South and southeastern United States.


Subject(s)
Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/therapy , Image Processing, Computer-Assisted/methods , Ophthalmology/organization & administration , Telemedicine/methods , Computer Communication Networks/legislation & jurisprudence , Computer Communication Networks/organization & administration , Computer Communication Networks/standards , Computer Security/legislation & jurisprudence , Computer Security/standards , Diagnosis, Computer-Assisted/methods , Diagnosis, Computer-Assisted/standards , Disease Management , Health Insurance Portability and Accountability Act , Humans , Image Processing, Computer-Assisted/standards , Mississippi , North Carolina , Ophthalmology/methods , Ophthalmology/standards , Telemedicine/legislation & jurisprudence , Telemedicine/standards , Tennessee , United States
20.
Telemed J E Health ; 17(10): 814-37, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21970573

ABSTRACT

Ocular telemedicine and telehealth have the potential to decrease vision loss from DR. Planning, execution, and follow-up are key factors for success. Telemedicine is complex, requiring the services of expert teams working collaboratively to provide care matching the quality of conventional clinical settings. Improving access and outcomes, however, makes telemedicine a valuable tool for our diabetic patients. Programs that focus on patient needs, consider available resources, define clear goals, promote informed expectations, appropriately train personnel, and adhere to regulatory and statutory requirements have the highest chance of achieving success.


Subject(s)
Diabetic Retinopathy/diagnosis , Health Policy , Telemedicine/methods , Diabetic Retinopathy/pathology , Guideline Adherence , Humans , Program Development , Program Evaluation , Telemedicine/instrumentation , Telemedicine/organization & administration , United States
SELECTION OF CITATIONS
SEARCH DETAIL